Purchase Order HHSN276201500060P

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $8,880.15 on August 9, 2016. Work was performed in Carlsbad, California. The order was firm fixed price with an ultimate completion date of January 31, 2021. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $17,119.36 on March 21, 2018, for a maintenance agreement with an ultimate completion date of April 22, 2020.</p> <p>Work is performed in Carlsbad, California. The order is priced firm fixed price with no set-aside applied. Life Technologies operates as Thermo Fisher Scientific and is a subsidiary of Thermo Electron Corporation.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $4,332.33 on February 4, 2016, with completion on April 7, 2017. The order carries no set-aside designation. Performance occurs in Carlsbad, California. Life Technologies supplies scientific instruments, reagents, and consumables to federal agencies across research and medical sectors.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on September 15, 2017, valued at $58,800.00. This modification changed the vendor due to a novation agreement. Performance occurs in Carlsbad, California, with an ultimate completion date of February 28, 2018. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for a QuantStudio 5 (Fixed 384 Block) real-time PCR system with a firm fixed price ceiling of $34,300.00, awarded August 9, 2018, with completion by October 9, 2018. Performance takes place in Carlsbad, California. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $14,787.43 on September 11, 2013, with an ultimate completion date of September 30, 2014. Performance occurs in Grand Island, New York. The order is for firm fixed-price procurement of specialized biomedical research instruments or related laboratory equipment. No set-aside was used.</p>

The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $52,933.64 firm fixed price purchase order contract to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division. The contract is for the purchase and maintenance of a QuantStudio12K Flex Open Array system and includes two option periods. Performance will take place in Carlsbad, California through November 2026. The original solicitation...